Mazindol treatment for heroin dependence and substance use disorder
AssigneeNLS Pharmaceutics AG
InventorAlexander C. Zwyer
Life of this patent
Estimating the term…
Abstract
The present invention relates to mazindol for use in the treatment of dependence and substance use disorder, wherein the substance is an opioid, a composition comprising mazindol and optionally a pharmaceutically acceptable carrier or excipient and/or a diluent, for use in the treatment of substance abuse disorder, wherein the substance is an opioid, and a method of treatment of substance abuse disorder comprising administering mazindol or composition comprising mazindol to a subject, wherein the substance is an opioid. The opioid is preferably heroin.
Claims9
A method of treatment of substance abuse disorder comprising administering mazindol or composition comprising mazindol to a subject, wherein the substance is an opioid and mazindol is administered daily at a daily dosage range of between 3 mg and 16 mg.
Dependencies are inferred from the claim text.